Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  2,634 results for ""REVERSE transcriptase inhibitors""

Your Filters

Publication : hiv medicine
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.

Subjects: HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Integrase Inhibitors/HIV Integrase Inhibitors/HIV Integrase Inhibitors/*therapeutic use ; HIV-1/HIV-1/HIV-1/*genetics

  • Source: HIV medicine [HIV Med] 2020 Oct; Vol. 21 (9), pp. 599-606. Date of Electronic Publication: 2020 Jun 26.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.

  • Authors : Girard PM; Department of Infectious and Tropical Diseases, Hôpital Saint-Antoine, AP-HP, INSERM UMR S 1136, Paris, France.; Antinori A

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects ; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*adverse effects ; Darunavir/Darunavir/Darunavir/*adverse effects

  • Source: HIV medicine [HIV Med] 2017 Jan; Vol. 18 (1), pp. 5-12. Date of Electronic Publication: 2016 Jun 09.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study.

  • Authors : Mwasakifwa GE; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.; Amin J

Subjects: Biomarkers/Biomarkers/Biomarkers/*metabolism ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; Hip/Hip/Hip/*diagnostic imaging

  • Source: HIV medicine [HIV Med] 2020 Sep; Vol. 21 (8), pp. 492-504. Date of Electronic Publication: 2020 Jun 23.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors.

  • Authors : Simpson KN; Medical University of South Carolina, Charleston, SC, USA.; Chen SY

Subjects: Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*economics ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*epidemiology ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: HIV medicine [HIV Med] 2014 Sep; Vol. 15 (8), pp. 488-98. Date of Electronic Publication: 2014 Mar 18.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudy.

  • Authors : Valantin MA; INSERM UMR-S 943 and University Pierre and Marie Curie (UPMC), Paris, France. ; Kolta S

Subjects: Body Fat Distribution*; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*administration & dosage

  • Source: HIV medicine [HIV Med] 2012 Sep; Vol. 13 (8), pp. 505-15. Date of Electronic Publication: 2012 Mar 14.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.

  • Authors : Van Welzen B; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands.; Mudrikova T

Subjects: Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*drug therapy ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects

  • Source: HIV medicine [HIV Med] 2012 Aug; Vol. 13 (7), pp. 448-52. Date of Electronic Publication: 2012 Mar 14.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline.

Subjects: Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*therapeutic use ; HIV-1/HIV-1/HIV-1/*drug effects

  • Source: HIV medicine [HIV Med] 2012 Aug; Vol. 13 (7), pp. 398-405. Date of Electronic Publication: 2012 Mar 14.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227.

Subjects: HIV-1*; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*administration & dosage

  • Source: HIV medicine [HIV Med] 2008 Nov; Vol. 9 (10), pp. 883-96. Date of Electronic Publication: 2008 Sep 14.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years.

Subjects: HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV-1/HIV-1/HIV-1/*drug effects ; Protease Inhibitors/Protease Inhibitors/Protease Inhibitors/*administration & dosage

  • Source: HIV medicine [HIV Med] 2018 Oct; Vol. 19 (9), pp. 662-667. Date of Electronic Publication: 2018 Jul 03.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.

  • Authors : Orkin C; Infection and Immunity, Barts Health NHS Trust, London, UK.; Llibre JM

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/Antiretroviral Therapy, Highly Active/*methods ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: HIV medicine [HIV Med] 2018 Jan; Vol. 19 (1), pp. 18-32. Date of Electronic Publication: 2017 Jul 24.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Connect Read More Add to Saved list
×
  • 1-10 of  2,634 results for ""REVERSE transcriptase inhibitors""